Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: A meta-analysis

BACKGROUND: Diffusion-weighted imaging (DWI) is increasingly used to identify pathological complete responses (pCRs) to neoadjuvant chemotherapy (NAC) in breast cancer. The aim of the present study was to assess the utility of DWI using a pooled analysis. MATERIALS AND METHODS: Literature databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Wei, Jin, Weiwei, Liu, Daihong, Wang, Jian, Geng, Chengjun, Chen, Lihua, Huang, Xuequan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805538/
https://www.ncbi.nlm.nih.gov/pubmed/29467952
http://dx.doi.org/10.18632/oncotarget.23195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805538/
https://www.ncbi.nlm.nih.gov/pubmed/29467952
http://dx.doi.org/10.18632/oncotarget.23195

Ejemplares similares